SELQUINOX

SELQUINOX is a patent-pending nutraceutical tablet formulation that is a redox-active pro-oxidant. The SEL in the name is for SELENIUM and the QUIN is for QUINONE, OX denotes OXIDATION. SELQUINOX is a selenium and quinone based pro-oxidant that selectively increases ROS in cancer cells. SELQUINOX is composed of sodium selenite, a natural quinone, vitamin B6 (P5P), iron, copper, zinc and manganese. All active ingredients are highly bioavailable.

SELQUINOX is essentially the NORI protocol within a single tablet to simplify administration and lower cost. The NORI protocol is proving to be highly effective and the single tablet approach is proving to be equally effective. No more reaching for multiple bottles of supplements and nutraceuticals. SELQUINOX is compatible with all conventional therapies.

The dosages of all of the active ingredients in SELQUINOX are well below what would cause any adverse effects of toxicity. The combination of ingredients is highly synergistic allowing for very fafe dosages of all active ingredients. The tablet is formulated and manufactured for slow gradual release and is enteric coated to limit dissolution in the stomach. SELQUINOX is typically taken for 4-5 consecutive days per week with a 2-3 day washout interval.

SELQUINOX disables two key antioxidant systems, glutathione and thioredoxin. In addition, the quinone component both elevates oxidative stress and maintains redox recycling. Excessive oxidative stress triggers apoptosis and ferroptosis. Iron, copper, zinc and manganese are ferroptosis inducers.

SELQUINOX contains vitamin B6 (P5P) and iron which non-enzymatically degrades the amino acid cysteine which is necessary for glutathione synthesis. A plant-based diet is helpful in limiting the intake of cysteine (cystine).

Sodium selenite helps to enable natural killer cell activity against cancer cells. Vitamin B6 (P5P)

lowers the expression of PD-L1 enabling CD8+ T cells to recognize cancer cells as abnormal.